Polymorphism in the Matrix Metalloproteinase-2 Gene Promoter is Associated with Cervical Neoplasm Risk in Mexican Women

Biochemical Genetics

Volumn 46, Issue 3-4, 2008, Pages 137-144

  Baltazar Rodriguez, Luz M ^a   Anaya Ventura, Aristoteles ^a   Andrade Soto, Maricela ^a   Monrroy Guizar, Elisa A ^a   Bautista Lam, Jose R ^a   Jonguitud Olguin, Gregorio ^b   Cepeda Lopez, Friedman R ^b   Centeno Aguilar, Veronica A ^b   Gonzalez Hernandez, Nelida A ^a   Soriano Hernández, Alejandro D ^a   Ramirez Flores, Mario ^a   Lugo Trampe, Angel ^c   Rodriguez Sanchez, Iram P ^c   Newton Sanchez, Oscar A ^a   Delgado Enciso, Ivan ^a  

^a Universidad de Colima   (Mexico)

^b Secretaria de Salud del Estado de Colima   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Cervix neoplasms; First intercourse; Gelatinase A; Mexico; Risk factors

Indexed keywords

ANTINEOPLASTIC AGENT; GELATINASE A;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; COITUS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROL GROUP; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEXICO; POPULATION; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; COITUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MATRIX METALLOPROTEINASE 2; MEXICO; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); UTERINE CERVICAL NEOPLASMS;

EID: 43449129744     PISSN: 00062928     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10528-007-9136-4     Document Type: Article

References (21)

1. Ahmed MI, Salahy EE, Tawfiq H, Khalifa A, Hassan MM (2004) Matrix metalloproteinase-2, squamous cell carcinoma antigen, and tissue polypeptide-specific antigen expression in Egyptian patients with cervical carcinoma: relationship with prognosis. Dis Markers 20:333-343
2. Collins SI, Mazloomzadeh S, Winter H, Rollason TP, Blomfield P, Young LS, Woodman CB (2005) Proximity of first intercourse to menarche and the risk of human papillomavirus infection: a longitudinal study. Int J Cancer 114:498-500
3. Curran S, Murray GI (1999) Matrix metalloproteinases in tumor invasion and metastasis. J Pathol 189:300-308
4. Delgado-Enciso I, Cepeda-Lopez FR, Monrroy-Guizar EA, Bautista-Lam JR, Andrade-Soto M, Jonguitud-Olguin G, Rodriguez-Hernandez A, Anaya-Ventura A, Baltazar-Rodriguez LM, Orozco-Ruiz M, Soriano-Hernandez AD, Rodriguez-Sanchez IP, Lugo-Trampe A, Espinoza-Gomez F, Michel-Peregrina ML (2008) Matrix metalloproteinase-2 promoter polymorphism is associated with breast cancer in a Mexican population. Gynecol Obstet Invest 65:68-72
5. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174
6. Elander N, Soderkvist P, Fransen K (2006) Matrix metalloproteinase (MMP)-1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res 26:791-795
7. Franceschi S (2005) The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer. Recent Results Cancer Res 166:277-297
8. Gaiotto MA, Focchi J, Ribalta JL, Stavale JN, Baracat EC, Lima GR, Guerreiro da Silva ID (2004) Comparative study of MMP-2 (matrix metalloproteinase 2) immune expression in normal uterine cervix, intraepithelial neoplasias, and squamous cell cervical carcinoma. Am J Obstet Gynecol 190:1278-1282
9. Kahn JA, Rosenthal SL, Succop PA, Ho GY, Burk RD (2002) Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics 109:E5
10. Lin SC, Lo SS, Liu CJ, Chung MY, Huang JW, Chang KW (2004) Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J Oral Pathol Med 33:405-409
11. Miao X, Yu C, Tan W, Xiong P, Liang G, Lu W, Lin D (2003) A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res 63:3987-3990
12. Nasr M, Ayyad SB, El-Lamie IK, Mikhail MY (2005) Expression of matrix metalloproteinase-2 in preinvasive and invasive carcinoma of the uterine cervix. Eur J Gynaecol Oncol 26:199-202
13. Prescrire Int (2007) Human papillomavirus: often harmless but in some cases carcinogenic. Prescrire Int 16:115-119
14. Price SJ, Greaves DR, Watkins H (2001) Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 276:7549-7558
15. Qin H, Sun Y, Benveniste EN (1999) The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 274:29130-29137
16. Stamenkovic I (2000) Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 10:415-433
17. Tavassoéli FA, Devilee P (2003) World Health Organization: tumours of the breast and female genital organs (who/IARC classification of tumours). IARC Press, Lyon France
18. Woessner JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154
19. Xu EP, Huang Q, Lu BJ, Xing XM, Lai MD (2006) The correlation between polymorphisms of matrix metalloproteinase-2 and -9 genes and colorectal cancer of Chinese patients. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23:78-81
20. Yu C, Pan K, Xing D, Liang G, Tan W, Zhang L, Lin D (2002) Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 62:6430-6433
21. Zhou Y, Yu C, Miao X, Tan W, Liang G, Xiong P, Sun T, Lin D (2004) Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis 25:399-404